Revascularization in stable coronary artery disease: a combined perspective from an interventional cardiologist and a

David R Holmes1, David P Taggart2

  • 1Mayo Clinic College of Medicine and Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

European Heart Journal
|March 20, 2016
PubMed

Insights

For stable coronary artery disease, the debate continues regarding the best treatment between percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery. This review clarifies current understanding and identifies remaining uncertainties.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery bypass graft (CABG) surgery has been performed for 50 years.
  • Percutaneous coronary intervention (PCI) emerged over a decade later.
  • The optimal revascularization strategy for stable coronary artery disease (stable-CAD) remains a subject of ongoing debate.

Purpose of the Study:

  • To review the comparative effectiveness of PCI versus CABG in patients with stable-CAD.
  • To identify areas of consensus and disagreement in current clinical practice guidelines.
  • To highlight unresolved questions regarding the role of PCI and CABG in stable-CAD management.

Main Methods:

  • Systematic review of randomized trials, registry studies, and meta-analyses.
  • Analysis of evidence comparing PCI and CABG for stable coronary artery disease.
  • Synthesis of findings to address clinical uncertainties.

Main Results:

  • Evidence from approximately 20 randomized trials and numerous observational studies has been evaluated.
  • Key differences and similarities in outcomes between PCI and CABG for stable-CAD have been identified.
  • Areas requiring further investigation have been pinpointed.

Conclusions:

  • The relative merits of PCI and CABG for stable-CAD continue to be debated.
  • Understanding the current evidence is crucial for informed clinical decision-making.
  • Further research is needed to definitively establish the optimal revascularization strategy in specific patient subgroups.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
436
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
545
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
410
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411